Kestra Advisory Services’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,101
| Closed | -$343K | – | 2909 |
|
|
2024
Q4 | $343K | Buy |
4,101
+535
| +15% | +$44.7K | ﹤0.01% | 2127 |
|
|
2024
Q3 | $261K | Sell |
3,566
-30
| -0.8% | -$2.2K | ﹤0.01% | 2180 |
|
|
2024
Q2 | $246K | Sell |
3,596
-494
| -12% | -$33.8K | ﹤0.01% | 2254 |
|
|
2024
Q1 | $283K | Sell |
4,090
-1,987
| -33% | -$138K | ﹤0.01% | 2037 |
|
|
2023
Q4 | $435K | Sell |
6,077
-533
| -8% | -$38.2K | ﹤0.01% | 1607 |
|
|
2023
Q3 | $344K | Buy |
+6,610
| New | +$344K | ﹤0.01% | 1579 |
|
|
2022
Q1 | – | Sell |
-6,045
| Closed | -$316K | – | 2142 |
|
|
2021
Q4 | $316K | Buy |
+6,045
| New | +$316K | ﹤0.01% | 1578 |
|
|
2021
Q3 | – | Sell |
-5,000
| Closed | -$204K | – | 2190 |
|
|
2021
Q2 | $204K | Buy |
+5,000
| New | +$204K | ﹤0.01% | 1859 |
|